Life Science Incubator (LSI) celebrated a major milestone with the official launch of its cutting edge & largest co-working laboratory in Singapore at Elementum, located in JTC’s one-north business park. This launch further strengthens Singapore’s prominence as a premier life sciences hub in Asia Pacific.
The grand opening event was officiated by Guest-of-Honour, Senior Minister of State Low Yen Ling, alongside Altea Investments CIO, John Ratcliffe and Life Science Incubator Director, Zeïna Henni. The event drew key stakeholders from Singapore’s life sciences ecosystem, including representatives from research institutions, accelerators, and industry leaders.
LSI's new state-of-the-art, fully-equipped co-working laboratory at Elementum will support startups, entrepreneurs, and multinational firms to scale their operations in this vital life sciences area. With this expansion, LSI has tripled its laboratory space, reinforcing its position as Singapore’s leading independent provider of co-working laboratory solutions. Providing flexible lab and office solutions that can be customized to meet the needs of life science companies, the working laboratory is ideal for startups and established companies alike. Besides open lab spaces, Elementum offers large private suites that house dedicated tissue culture rooms with highly optimized controls, all with flexible contract arrangements. Wet labs and office spaces can be customized to tenants' specifications. Additionally, Elementum fosters a vibrant and innovative community, boosting opportunities for networking and collaboration.
"Our mission at LSI is to remove barriers for life sciences startups and innovators by providing the critical infrastructure they need to accelerate breakthroughs," said Zeïna Henni, Director of LSI. "Singapore’s life sciences sector is entering an exciting phase of growth, and we're proud to be part of this journey, supporting the next wave of transformative advancements in healthcare and biotechnology."
"The expansion of LSI at Elementum marks a pivotal step in strengthening Singapore’s position as a leading life sciences hub in the Asia-Pacific. This co-working laboratory will provide the critical space and resources needed for startups, researchers, and global firms to accelerate advancements in biotechnology and medical innovation,” shared John Ratcliffe, CIO, Altea Investments.
Looking ahead, LSI is set to expand into the broader APAC region, with Australia as its next key market. Australia presents a highly attractive market with its strong focus on research and development, efficient clinical trial processes, and access to top-tier educational institutions and talent. Leveraging three years of active engagement in the Australian life sciences ecosystem, LSI has built strong relationships with the community, academia, and government agencies. The company is currently in discussions through its established network about the potential launch of its first LSI Australia location later this year.
